SCHEMBL17865303

SCHEMBL17865303

CCC(=O)c1ccc(C2(C(F)(F)F)N=N2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.47
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GABRA1 P14867 3/20 0.42
GABRB2 P47870 2/20 0.42
DUSP3 P51452 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
PTPN1 P18031 1/20 0.39
GSK3B P49841 1/20 0.39
NOS1 P29475 2/20 0.38
SIRT2 Q8IXJ6 1/20 0.35
ATM Q13315 1/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
PDK2 Q15119 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079671 0.81 GABRA1 (0.43) KIF11MAPTSMN1; SMN2L3MBTL1GABRA1
SCHEMBL13073461 0.81 KIF11 (0.50) KIF11MAPTSMN1; SMN2L3MBTL1GABRA1
SCHEMBL17600536 0.80 KIF11 (0.43) KIF11MAPTL3MBTL1GABRA1GABRB2
SCHEMBL13259618 0.80 GABRA1 (0.56) KIF11MAPTGABRA1GABRB2NOS1
SCHEMBL15355926 0.80 HDAC4 (0.48) KIF11MAPTGABRA1GABRB2HPGD
SCHEMBL26598413 0.79 KIF11 (0.49) KIF11GABRA1GABRB2DUSP3GABRG2
SCHEMBL2380170 0.79 KIF11 (0.51) KIF11SMN1; SMN2NOS1HPGDALDH1A1
SCHEMBL19090382 0.78 MAPT (0.44) MAPTSMN1; SMN2L3MBTL1PTPN1GSK3B
SCHEMBL19733924 0.78 KIF11 (0.48) KIF11GABRA1GABRB2DUSP3GABRG2
SCHEMBL14655025 0.78 KIF11 (0.51) KIF11SMN1; SMN2HPGDHTTPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 US disclosed
WO-2016096897-A1 COSMETIC METHOD FOR CONTROLLING ODORS L'OREAL (FR) 2016-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A KIF11 3346/4885MAPT 4761/4885SMN1; SMN2 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.